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Abstract: Mass spectrometry has served as a major tool for the discipline of proteomics to catalogue proteins in an un-
precedented scale. With chemical and metabolic techniques for stable isotope labeling developed over the past decade, it 
is now routinely used as a method for relative quantification to provide valuable information on alteration of protein 
abundance in a proteome-wide scale. More recently, absolute or stoichiometric quantification of proteome is becoming 
feasible, in particular, with the development of strategies with isotope-labeled standards composed of concatenated pep-
tides. On the other hand, remarkable progress has been also made in label-free quantification methods based on the num-
ber of identified peptides. Here we review these mass spectrometry-based approaches for absolute quantification of pro-
teome and discuss their implications. 
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1. INTRODUCTION 
  Proteomics is a promising discipline in the aim of profil-
ing of whole proteins, identifying their modifications and 
interactions, and providing abundance information. In so 
doing, it contributes to reveal molecular systems underlying 
various biological phenomena and provide valuable informa-
tion on disease mechanisms as well as biomarkers for diag-
nosis and prognosis. Mass spectrometry (MS) enables pro-
tein identification and quantification in a large-scale, and 
hence serves as the most powerful tool to address these pur-
poses of proteomics [1-5].  
  In general, proteins are digested with specific proteases, 
such as trypsin, into a distinct set of peptides. These peptides 
are then ionized and introduced into MS instruments. Tan-
dem mass spectrometry (MS/MS) has been widely used in 
proteome analysis, where a peptide ion to be analyzed is 
selectively isolated and fragmented to obtain an MS/MS 
spectrum. Since the pattern of these fragment ions is depend-
ent on the amino acid sequence of its precursor ion, it can be 
compared with theoretical ones calculated from protein se-
quences in the database. If the MS/MS spectrum measured 
for a peptide shows a reliable matching with one of the theo-
retical spectra, the peptide is identified as the one used for 
the calculation of the theoretical spectrum. 
  Since the MS/MS analysis identifies individual peptides, 
it is amenable to be combined with liquid chromatography 
(LC) as a peptide separation step that precedes MS. LC–
MS/MS is a commonly used technical platform, where pep-
tides are separated with reverse-phase LC, directly ionized  
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via electrospray ionization, and introduced into mass spectro-
meter. Alternatively, peptides eluted from LC are separately 
collected and spotted on a plate for matrix assisted laser 
desorption ionization (MALDI). These systems especially 
have an impact on the analysis of highly complex samples 
composed of a great number of proteins. Their power can be 
further enhanced by the use of multidimensional separation 
with cation-exchange and reverse-phase LC to identify more 
than 1,000 proteins at once [6-8]. Thus, MS is a high 
throughput and powerful protein identification system.  
  MS has also an ability to provide quantitative informa-
tion in proteome analysis. Various strategies have been de-
veloped to detect relative changes in protein abundance be-
tween the samples to be compared [9, 10]. They can be di-
vided into two categories; one is based on stable isotope la-
beling and the other is the so-called label-free method.  
  In the former, samples to be analyzed for relative quanti-
fication are differentially labeled with stable isotope, com-
bined, and simultaneously subjected to MS. Ratio of peak 
intensity between the ions of an isotope pair (i.e., light and 
heavy peptide ions) gives relative difference in abundance of 
the protein from which the peptide is derived. Various meth-
ods have been developed for stable isotope labeling of pro-
teome, including chemical, proteolytic, and metabolic label-
ing ones [11-15].  
  By contrast, in the latter or label-free methods, samples 
to be compared are individually introduced into mass spec-
trometer, and peak intensities or frequencies of identification 
measured in separate runs are compared to calculate relative 
change in protein abundance [9, 10]. Accordingly, label-free 
strategies are much simpler but more error-prone than iso-
tope labeling ones, due to systematic variations among indi-
vidual runs and stochastic nature of the indices used for cal-
culation. 264    Current Genomics, 2008, Vol. 9, No. 4  Kito and Ito 
  Although these techniques are widely used for relative 
quantification in proteomics studies, the ultimate goal of 
quantitative proteomics is definitely the absolute measure-
ment of protein abundance. Absolute quantification provides 
a far more precise description of molecular events in the bio-
logical processes than relative quantification. Furthermore, 
absolute quantification data can be readily exchanged among 
different studies to facilitate data integration. Recent advent 
in proteomics has enabled MS-based absolute quantification 
by extending the technologies originally developed for rela-
tive quantification. Thus, we review both relative and abso-
lute quantification techniques either with or without stable 
isotope labeling. 
2. QUANTITATIVE TECHNIQUES BASED ON STA-
BLE ISOTOPE LABELING 
  In stable isotope labeling methods, quantitative values 
were calculated based on ratio of peak intensity between 
isotope pair ions, one of which contains only native isotopes 
whereas the other bears a number of heavy stable isotopes. 
Having the same chemical properties, two peptide ions of an 
isotope pair can be simultaneously introduced into mass 
spectrometer but clearly distinguished by their mass differ-
ence. Simultaneous measurement of ion intensities in the 
same analysis eliminates not only run-to-run variations in 
performance of LC and MS, amounts of injected sample, and 
ion-suppression effect of co-eluting ions, but also limitations 
in intrinsic dynamic range of each MS, thereby enabling 
more accurate and reliable quantification. 
2.1. Relative Quantification 
  In relative quantification, samples to be compared are 
differentially labeled with stable isotopes. These samples are 
then combined and subjected to quantitative MS. Peak inten-
sity ratio between heavy and light peptides is measured to 
learn relative change in protein abundance. Various labeling 
methods have been developed, including chemical, prote-
olytic, isobaric, and metabolic labeling techniques. 
  The most popular method of chemical labeling would be 
the isotope-coded affinity tags (ICAT) approach, in which a 
compound containing stable isotope is coupled to Cys resi-
dues in proteins [16, 17]. Different isotopomers of the com-
pound, each having a unique mass, are used for labeling of 
different samples. Following this differential labeling proce-
dure, the samples are mixed and subjected to protease diges-
tion followed by affinity-purification of Cys-containing pep-
tides. Besides the original ICAT methods, strategies have 
been reported for chemical labeling of carboxyl, amino, or 
thiol moieties [11-15, 18]. In the labeling method coupled 
with hydrolysis, proteins are digested with protease in the 
presence of 
18O-labeled water so that 
18O is incorporated at 
the carboxyl end of each peptide [19, 20]. Another in vitro 
labeling method is an isobaric tagging strategy, in which 
each tag has an identical mass but contains stable isotopes at 
unique atomic positions to generate a reporter ion with a 
unique mass-charge ratio upon fragmentation [21, 22].  
  An obvious advantage of these in vitro labeling methods 
is that they can be applied to tissue samples, for which in 
vivo labeling is difficult or practically impossible. On the 
other hand, they require tangled procedures for sample han-
dling and labeling. Accordingly, the samples to be compared 
are forced to be combined at later stages of the procedure, 
allowing variations in earlier steps to affect accuracy of 
quantification. 
  An alternative labeling method is the in vivo metabolic 
incorporation of stable isotopes, where cells are cultivated in 
a medium supplemented with an appropriate stable isotope-
labeled nutrient that is essential for growth to achieve label-
ing of whole proteome [23-26]. Amino acids are usually 
used as the labeled essential nutrient, and such a procedure is 
often called SILAC for stable isotope labeling by amino ac-
ids in cell culture [24]. Proteome from multicellular and 
mammalian organisms, such as worm, fly, and rat, can be 
also metabolically labeled by feeding stable isotope-labeled 
microorganisms [27, 28].  
  An obvious advantage of these metabolic labeling meth-
ods over the chemical and hydrolytic ones is that protein 
samples can be combined at much earlier step in the proce-
dure, for instance, at the stage of cell harvest. Accordingly, 
the effect of experimental errors can be minimized. On the 
other hand, it is difficult, or even impossible, to complete 
stable isotope labeling of animal tissues and metabolically 
inactive cells. To partly circumvent these difficulties, an in-
teresting method termed culture-derived isotope tags 
(CDITs) was developed, in which relative abundance of pro-
teins in the tissues refractory to metabolic labeling are quan-
tified using the isotope-labeled proteome of a cell line de-
rived from the tissue [29]. 
  These methods have been widely implemented in relative 
quantification in proteomics studies. With the remarkable 
analytical power of multidimensional LC, relative differ-
ences of several hundred proteins were successfully quanti-
fied among yeast cells grown in different culture conditions 
[30-33]. The strategy was also applied to distinguish con-
taminants in purification; quantitative comparison between 
purified and mock-purified samples revealed specific com-
ponents in a protein complex and a cellular compartment 
[34, 35]. It can be combined with specific purification tech-
niques for protein complex and post-translationally modified 
peptides to grasp dynamics of protein interactions [34, 36-
40] and phosphorylation in stimulated cells [38, 41-45]. 
2.2. Absolute Quantification 
  In MS-based absolute quantification, a known amount of 
isotope-labeled authentic standard is mixed with the analyte, 
and the mixture is introduced into mass spectrometer. The 
absolute amount of the analyte is calculated from the ratio of 
ion intensity between the analyte and its standard. Accord-
ingly, known amounts of stable isotope-labeled synthetic 
peptides, proteins, or peptide concatemers have been used as 
a standard for absolute or stoichiometric quantification of 
proteins. Different types of standard are added to the samples 
at the different stages of the procedure, and have distinct 
pros and cons (Fig. 1 and Table 1). Accordingly, the most 
suitable standard should be selected, depending on the pur-
pose of the experiment, or on whether it intends to quantify a 
small number of targets including their post-translational 
modifications, obtain highly accurate data for a single unique 
protein, or measure absolute or stoichiometric abundance of 
many proteins. MS-Based Approaches Toward Absolute Quantitative Proteomics  Current Genomics, 2008, Vol. 9, No. 4    265 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Strategies for absolute quantification using stable iso-
tope-labeled standards. 
Different types of stable isotope standard are spiked at different 
steps of the sample preparation procedure. Intact protein standard 
can be spiked as soon as proteins are extracted from cells, tissues or 
bloods, even if subsequent fractionation steps (e.g., SDS-PAGE, gel 
filtration) are included in the procedure. While synthetic peptide 
standard is spiked before or after digestion with protease, peptide-
concatenated standard has to be spiked prior to digestion to allow 
co-proteolysis of target and standard. Note that synthetic peptide 
and peptide concatenated standard have to be spiked after protein 
fractionation steps.  
2.2.1. Quantification with Stable Isotope-Labeled Peptide 
Standard 
  In the original report that uses a stable isotope-labeled 
peptide as an internal standard for MS-based absolute quanti-
fication [46], the amount of endogenous enkephalin in 
thalamus extract was measured with an 
18O-incorporated 
standard peptide. To reduce background noises and enhance 
the specificity of measurement, multiple reaction monitoring 
(MRM) mode, in which intensity of multiple fragment ions 
but not the peptide ion are monitored, was used for absolute 
quantification of enkaphalin in human tissue [47].  
  Stable isotope-labeled peptides were initially applied to 
absolute quantification of a specific protein [48]; three pep-
tides from apolipoprotein A-I were selected, 
2H- and 
13C-
labeled, and used as standard for quantification of its abun-
dance in human serum. To increase specificity and sensitiv-
ity, measurement of difference in intensities of fragment 
ion(s) [SRM (selected reaction monitoring) or MRM mode] 
between analyte and standard peptide was implemented in 
absolute quantification of protein. Expression level of G pro-
tein-coupled receptor rhodopsin in rod outer segment mem-
brane was quantified using a 
2H-labeled synthetic peptide 
[49]. For quantification of low abundance proteins, enrich-
ment of the target protein is necessary. For instance, follow-
ing SDS-PAGE separation of yeast extract, a gel slice con-
taining the target protein was excised, mixed with 
13C and 
15N-labeled standard peptides, and subjected to trypsin diges-
tion followed by MS [50]. In this study, abundance of Sir2 
and Sir4 were determined as 10
3 copies per cell. Absolute 
abundance of proteins in blood or tissue was also quantified 
using synthetic peptides as isotope-labeled standards in the 
MRM mode. For instance, absolute amount of C-reactive 
protein, a well-known diagnostic marker for rheumatoid ar-
thritis, was measured in human serum depleted of abundant 
proteins (serum albumin and immunoglobulin G) [51]. Simi-
larly, GST- in human liver, a marker for acute hepatocyte 
damage, was quantified distinctly from other isozymes [52]. 
  More recently, stable isotope-labeled synthetic peptides 
were applied to simultaneous quantification of multiple pro-
Table 1.  Summary of Approaches for Absolute Quantification of Protein Abundance with Mass Spectrometry 
 
Standard  
Types 
Measured  
Values 
Spiking  
Time Point 
Normalization Accuracy  Coverage 
Applicability to 
Post-Translational 
Modification 
Noise Origins 
Synthetic peptide 
Ratio to  
standard 
Before or  
after digestion 
— Medium  Low  Applicable 
S/N of ion peak,  
Missed cleavage 
Intact protein 
Ratio to  
standard 
Just after protein 
extraction 
—  Very High  Low  Not  S/N of ion peak 
Isotope  
labeling 
Peptide concatemer 
(QconCAT, PCS) 
Ratio to  
standard 
Prior to  
digestion 
— High  Medium  Not 
S/N of ion peak, Missed 
cleavage (QconCAT) 
— 
Peak  
intensity 
— 
Average of most 
intense three peaks 
Low Medium  Not 
Variation of  
ionization efficiency 
Label-free 
— 
Spectral  
count 
— 
Observable  
peptides 
Low High  Not 
Stochastically  
calculated index 266    Current Genomics, 2008, Vol. 9, No. 4  Kito and Ito 
teins. For instance, the stoichiometry among the 10 compo-
nents of human spliceosomal U1 small ribonucleoprotein 
complex was determined using chemical labeling of sample-
derived and synthetic standard peptides with isotope-coded 
reagents after trypsin digestion [53]. Similarly, concentra-
tions of 8 endogenous proteins in human serum were quanti-
fied by spiking isotope-labeled standard peptides [54]. In 
another study, isotope-labeled peptides were applied to abso-
lute quantification of 32 key proteins in the postsynaptic den- 
sity of rat, including calmodulin-dependent protein kinase, 
synaptic GTPase-activating protein, glutamate receptors, and 
scaffold proteins [55]; the absolute and stoichiometric abun-
dance obtained from this study provided valuable informa-
tion on abundance of receptor subtypes and protein interac-
tions.  
  Taken together, isotope-labeled synthetic peptide is defi-
nitely a powerful tool for absolute quantification not only for 
cultured cells, but also for tissue or blood samples from ani-
mals and human. However, it is too expensive to synthesize 
multiple stable isotope-labeled peptides for quantification of 
multiple proteins. In this context, it is interesting to note that 
the CDIT strategy described above allows quantification of 
tissue proteins without any labeled synthetic peptides as fol-
lows [29]. Absolute amounts of the proteins in the cultured 
cell line labeled in vivo are determined with unlabeled syn-
thetic peptides. These quantified labeled proteins are, in turn, 
used as the standards for absolute quantification of unlabeled 
tissue proteins. Indeed, this strategy was successfully used to 
quantify103 proteins in the mouse brain. 
  Peptide standard can be used to quantify not only protein 
abundance but also post-translational modifications. Isotope-
labeled unphosphorylated and phosphorylated peptides can 
be used to quantify phosphorylation stoichiometry. For in-
stance, stoichiometry of phosphorylation at Ser-1126 of sepa- 
rase, which negatively regulates its activity, was measured in 
different stages of the cell cycle either in a peptide ion scan-
ning mode [56] or in SRM mode [50]. Simultaneous quanti-
fication of multiple phosphoryation sites was also reported. 
Two phosphorylated sites of cyclin-dependent kinases, which 
inhibit their activity, are regulated in a cell cycle-specific 
manner. Stoichiometry of four possible patterns of these 
phosphorylation sites was determined to reveal that isoforms 
unphosphorylated and phosphorylated at both sites were 
dominant in M-phase and S-phase, respectively, whereas 
those phosphorylated at either site were minorities [57].  
  Modifications other than phosphorylation can be quanti-
fied. For instance, abundance of polyubiquitin chain branched 
at the Lys-48 was measured in mammalian cells treated with 
or without the proteasome inhibitor MG132 [58]. Ubiquitina-
tion is mediated via an isopeptide bond between the carboxy-
terminal end of ubiquitin and the -amino group of a Lys 
residue in the substrate. Since the amino acid sequence at the 
C-terminal end of ubiquitin is Arg-Gly-Gly, tryptic digestion 
of ubiquitinated proteins produces peptides containing Lys 
conjugated with Gly-Gly or diglycine at its -amino group. 
In a study aiming at absolute quantification of ubiquitin con-
jugated sites, a peptide bearing diglycine-conjugated Lys 
residue was synthesized and used as an isotope-labeled stan-
dard. Topology of polyubiquitin chain of an in vitro ubiquit-
inated protein, or which of the seven Lys residues is used for 
branching, was also analyzed using ubiquitin-standard pep-
tides [59]. Beside phosphorylation and ubiquitination, abso-
lute quantification of farnesylation was reported for H-Ras 
using a 
2H-labeled, farnesylated carboxy-terminal peptide 
[60]. 
2.2.2. Quantification with Stable Isotope-Labeled Intact 
Protein 
  When a proteolytic standard peptide is used for absolute 
quantification, efficiency of protease digestion is critically 
important for accuracy, because incomplete digestion of the 
analyte leads to underestime its amount. While some studies 
optimized and monitored cleavage efficiency for specific 
peptides [48, 49], it is difficult to assess a large number of 
peptides in terms of cleavage efficiency. Notably, measured 
abundances of an analyte protein can differ substantially, 
depending on the tryptic peptides used as the standard, pre-
sumably because efficiency of trypsin digestion is different 
from one site to another [51]. In particular, when SDS-
PAGE is used as a pre-fractionation step, recovery of pep-
tides is affected not only by the efficiency of in-gel digestion 
but also by that of peptide extraction from gel slices [61].  
  An ideal standard for absolute quantification of a protein 
is obviously the protein per se that is labeled with stable iso-
tope, because it can be spiked at the earliest stage of sample 
preparation to minimize experimental errors and shares ex-
actly the same efficiency of protease digestion with the tar-
get proteins in the sample. For instance, concentrations of 
insulin in sera of normal individuals and diabetic patients 
were quantified with an isotope-labeled recombinant stan-
dard protein expressed in and purified from E. coli [62]. 
Similarly, 
15N-labeled recombinant standard proteins were 
used for absolute quantification of 6 proteins localized in 
postsynaptic density [63], and expression level of alcohol 
dehydrogenase isozyme ADH1C1 was quantified in human 
liver tissue using a 
13C- and 
15N-labeled recombinant intact 
protein [64].  
  An intriguing study was reported to directly compare two 
strategies, one with a synthetic peptide standard and the 
other with an intact protein standard, in absolute quantifica-
tion of Staphylococcus aureus superantigenic toxins spiked 
into drinking water and urine samples [65]. The amount 
quantified with the synthetic peptide standards was smaller 
than that obtained with the intact protein standard, presuma-
bly because of incomplete digestion of the toxins in sample. 
This result indicates the power of the strategy using an intact 
protein as a stable isotope standard. 
2.2.3. Quantification with Stable Isotope-Labeled Peptide-
Concatenated Standard 
  Although the strategies using synthetic peptides or intact 
proteins as stable isotope-labeled standards allow us to learn 
absolute amounts of specific proteins, a large scale analysis 
requires preparation and handling of many standard pep-
tides/proteins, thereby raising many concerns. First, it is ex-
pensive to prepare many stable isotope-labeled synthetic 
peptides. Second, the purity of synthetic peptides is variable 
from one to another and is often unsatisfactory for accurate 
quantification. Third, it is also a daunting task to express and 
purify many recombinant proteins as stable isotope-labeled 
standards. Forth, since individual standards are differentially MS-Based Approaches Toward Absolute Quantitative Proteomics  Current Genomics, 2008, Vol. 9, No. 4    267 
lost during the course of experiments, one cannot guarantee 
their precise amounts or even their equimolarity. 
  To overcome these bottlenecks, two groups independ-
ently conceived a strategy that uses a peptide concatemer as 
a standard, namely QconCAT [66] and PCS for peptide-
concatenated standard [67]. In both strategies, tryptic pep-
tides used for quantification are concatenated into a single 
artificial protein. This protein was metabolically labeled with 
stable isotope in E. coli, purified, and mixed with a protein 
sample to obtain absolute or stoichiometric quantities of 
multiple proteins (Fig. 2). This peptide concatenation strat-
egy eliminates the daunting task for the preparation of many 
standard peptides/proteins. Furthermore, since all isotope-
labeled peptides are contained in a single protein, they are 
always added to the sample at exactly the same molarity. The 
QconCAT approach provided absolute quantitative data of 
more than 10 proteins in chick skeletal muscle of different 
developmental stages [66, 68]. It was also used for quantifi-
cation of plasma proteins [69]; absolute amounts of 13 pro-
teins in human plasma of 20–10,000 fmol/μl concentrations 
were successfully measured in an MRM mode. 
  However, it should be noted that, as discussed above, one 
of the critical keys for accurate quantification is to equalize 
cleavage efficiency between the analyte and its standard. It 
was shown that the amino acid context around a trypsin clea- 
vage site substantially affects the efficiency of its digestion 
[70, 71]. In contrast to QconCAT, PCS contains each stan-
dard peptide with its natural flanking sequences on both 
sides to faithfully recapitulate the efficiency of tryptic cleav-
age of parental proteins or analytes (Fig. 2). The involve-
ment of flanking sequences was demonstrated to improve the 
accuracy of quantification, and led to accurate quantification 
of stoichiometry among 5 subunits in eIF2B stable complex 
of yeast within 5% measurement error [67]. Similarly, others 
successfully quantified absolute and stoichiometric abun-
dance of each subunit of transducin, a heterotrimeric G-
protein, using a PCS incorporating the flanking sequences of 
each tryptic peptide [72]. Notably, the QconCAT strategy, 
which lacks flanking sequences, resulted in an underestima-
tion of the amounts of Staphylococcus toxins spiked into 
drinking water and urine samples when compared to the stra- 
tegy using an intact protein standard [65], presumably be-
cause the target protein was less efficiently digested than the 
QconCAT. These studies highlight the importance of incor-
poration of flanking sequences into the standard to ensure 
highly accurate absolute or stoichiometric quantification. 
  Peptide-concatenated artificial proteins are, in most 
cases, recovered in insoluble fraction. Since the order of the 
peptides affect the success rate of production in an in vitro 
translation system [73], an efficient algorithm is needed to 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Stable isotope-labeled and peptide-concatenated standard for absolute or stoichiometric quantification. 
In strategy using peptide-concatenated standard, tryptic peptides to be quantified are selected from target proteins and concatenated to gener-
ate an artificial protein, which serves as a stable isotope-labeled standard. Colored fragments denote the selected tryptic peptides. Target and 
standard peptides that form an isotope pair are indicated by similar colors (blue and light blue, red and pink, and green and light green). Pep-
tide-concatenation not only guarantees equimolar spiking of every standard peptide but also eliminates the need to prepare many standard 
molecules. Two types of peptide-concatenated standard, namely QconCAT [66] and PCS [67], have been reported. While each peptide in-
cluded in QconCAT is the tryptic peptide per se, that in PCS carries its natural flanking sequences at both sides to faithfully recapitulate the 
efficiency of proteolytic cleavage in the target protein. Even a peptide excised less efficiently from the target protein (colored in pink) can be 
precisely quantified with PCS, because its standard (colored in red) is also excised from the PCS at a similar efficiency.  268    Current Genomics, 2008, Vol. 9, No. 4  Kito and Ito 
optimize the peptide order for improvement of the solubility 
of peptide-concatenated standard proteins.  
  The insoluble-prone nature of peptide-concatenated arti-
ficial proteins not only makes their handling difficult but 
also limits their sizes. Thus, many standards have to be used 
concurrently in a large scale analysis. It then becomes impor-
tant to know precise amounts of the standards to integrate 
quantitative data obtained from each of them. To solve this 
issue and to expand the scale of analysis, we proposed a hi-
erarchical PCS strategy, in which each primary PCS includes 
a unique “bar-code” peptide and is quantified by a secondary 
PCS composed of the bar-code peptides [67]. It is also pos-
sible to adjust the amount of each primary PCS to extend the 
dynamic range of quantification.  
3. QUANTITATIVE TECHNIQUES BASED ON LA-
BEL-FREE STRATEGIES 
  Stable isotope-labeling strategies described above have 
enabled quantitative MS-based proteomics. However, they 
inevitably require additional steps for isotope labeling and/or 
preparation of the standards. By contrast, the so-called label-
free (standard-free) method is simple and requires no addi-
tional experimental steps; it just exploits peak intensity of 
peptide ion or identification frequency for a particular pro-
tein to obtain quantitative data (Fig. 3 and Table 1). While 
absolute quantification with stable-isotope labeling can 
quantify only the proteins with corresponding isotope stan-
dards, label-free strategies can, in principle, quantify any 
protein from which a peptide is unambiguously identified. 
This implies that the label-free methods are amenable to a 
large scale analysis. On the other hand, they provide less 
accurate quantitative values than those by label-based ones, 
due to run-to-run variations and a stochastic nature of the 
measurement. 
3.1. Relative Quantification 
3.1.1. Quantification Based on Peak Intensity 
  In relative quantification based on peak intensity, each 
sample is separately subjected to MS. Peptide peak intensity 
is measured in individual runs and change in protein abun-
dance is calculated via a comparison among different analy-
ses. This approach has been applied to quantification of rela-
tive change in protein expression [74, 75] and quantitative 
profiling of purified proteins to identify bona fide compo-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Label-free methods for absolute quantitative proteomics. 
In the strategy based on intensities of individual peptides, average of intensities of the three most intense ions is used to generate reliable 
absolute quantitative data. In the strategy based on identification frequency, spectral count (i.e., number of identified MS/MS spectra) is the 
most useful indicator to estimate protein abundance. Since larger proteins tend to provide more observable peptides than smaller ones, each 
spectral count is divided by observable peptide number for normalization to ensure accuracy of quantification. For instance, while proteins A 
and C present at the same abundance have different spectral counts (i.e., 6 and 3, respectively), they share the same normalized spectral count 
(i.e., 1.5). MS-Based Approaches Toward Absolute Quantitative Proteomics  Current Genomics, 2008, Vol. 9, No. 4    269 
nents of a protein complex and reveal dynamics of protein-
protein interactions [76, 77]. 
  In contrast to stable isotope labeling methods, label-free 
approach based on peak intensity is error-prone [78], due to 
run-to-run variations in performance of LC and MS, amounts 
of injected samples, and ion-suppression effect of co-
detected ions, and also due to limited dynamic range of each 
mass spectrometry. Systematic errors induced by the first 
two factors can be normalized by spiking an identical 
amount of standard protein into every sample to be com-
pared [79, 80], the total ion intensities over the entire analy-
sis [74], or using the average intensity ratios between target 
peptide and co-eluting peptides as a pseudo internal standard 
[81]. Furthermore, high reproducibility of retention time for 
each peptide is required to extract an ion pair from different 
runs, when either, but not both, of the pair is identified in 
MS/MS analysis. Otherwise, an algorithm to align peptide 
ion maps of different analyses has to be developed to com-
pare peak intensity of each peptide ion [82]. 
3.1.2. Quantitative Approaches Based on Identification 
Frequency 
  An increase in protein abundance usually results in an 
increase in the number of identifications of its tryptic pep-
tides, and vice versa. Thus, identification frequency, which is 
the number of identified peptides, precursor ions, or MS/MS 
spectra (spectral count) for each protein, can be used to esti-
mate relative difference in protein abundance. Peptide identi-
fication number was originally applied to quantitative pro-
teomics analysis of urine sample from healthy donors and 
patients [83]. Among the factors of identification frequen-
cies, spectral count showed the highest correlation with rela-
tive protein abundance, suggesting it to be the best index for 
relative quantification [8]. Relative quantitative approaches 
were also taken to compare protein expression in yeast and 
mammalian cells under different culture conditions [74, 84, 
85], and the screening of phosphotyrosine-binding proteins 
in mammalian cells [86]. 
  An intriguing study compared relative abundance calcu-
lated from the spectral count with that obtained using a sta-
ble isotope-labeling method [85]. When only the peptides 
with high signal-to-noise ratio in the extracted ion chroma-
togram were included in the calculation, the two methods 
showed a positive correlation within 1.5-fold error. Quantita-
tive data determined by isotope labeling and spectral count 
would compensate each other to improve accuracy of quanti-
fication. 
3.2. Absolute Quantification 
3.2.1. Quantification Based on Peak Intensity 
  Although difference in peak intensity has been exploited 
for relative quantification, individual peptides differ in pro-
pensities to be ionized and in efficiencies for isolation and 
detection, and they are also dependent on MS equipments. 
Accordingly, ion intensities can be different even among the 
peptides present at the same molarity (e.g., peptides derived 
from a single protein). Thus, these differences should be 
corrected for absolute quantification. 
  To reduce the effect of variance in individual peak inten-
sities, average of ion intensities for multiple peptides in a 
particular protein was used as a quantitative value to estimate 
protein abundance [87]. In this study, a relationship was ob-
served between protein abundance and average of intensities 
of the three most intense peptide ions. The average for the 
three most intense ions had an ability to predict the abun-
dance of known amount of proteins with less than ~15% 
error. Stoichiometry of GroEL and GroES of E.coli was suc-
cessfully quantified to be 2:1, consistent with known struc-
ture of this molecular chaperone. While proven useful by an 
evaluation using a mixture of known amounts of proteins, 
this strategy may generate a large error for low abundance 
proteins, for which only a small number of peptides can be 
identified, and fails to quantify proteins from which only one 
or two peptides are identified. 
3.2.2. Quantitative Approaches Based on Identification 
Frequency 
  Label-free approaches based on identification frequency, 
which had been applied to relative quantification, was also 
modified to estimate absolute protein abundance. Larger 
proteins have more peptides that are detectable by MS than 
smaller ones. Accordingly, the number of identified peptides, 
precursor ions, and MS/MS spectra (spectra count) may be 
different between the two proteins that exist at the same 
abundance but differ in sizes. Thus, to know absolute or 
stoichiometric quantity, one should use the percentile frac-
tion of the protein sequence covered by identified peptides or 
normalize the number of identifications by either protein size 
or observable peptide kinds.  
3.2.2.1. Normalization with Protein Size 
  It was observed that the number of identified peptides 
correlates with the codon adaptaion index of the protein, 
which serves as an indicator of protein abundance [6]. The 
number of identified peptides per protein molecular weight 
provided stoichiometric abundance for clathrin and its adap-
tor proteins in clathrin-coated vesicles [88]. Clustering 
analysis using abundance index, or the number of identified 
precursor ions per protein molecular weight, successfully 
identified proteins associated with SAGA, a histone acetyl-
transferase complex, as those having a similar pattern of pu-
rification abundance [89]. Spectral count per protein length 
was further optimized to give normalized spectral abundance 
factor (NSAF); the latter index is calculated by dividing the 
former by the sum of all spectral count per protein length in 
each MS run to eliminate variation of each analysis [90]. 
Quantitative analysis with NSAF revealed the subunit 
stoichiometry of yeast Mediator, a transcriptional coactivator 
complex [91]. A study examined correlations between rela-
tive protein abundance and three indices (i.e., sequence cov-
erage, identified peptide number, and spectral count) by 
spiking known amounts of 6 different proteins into yeast cell 
extract [8]. While sequence coverage and peptide numbers 
failed to linearly correlate with relative abundance, a strong 
correlation was observed between relative abundance and 
spectral count with 2-order of magnitude. Furthermore, spec-
tral count per molecular weight of each protein had a linear 
correlation with stoichiometry of 6 different proteins [8], 
suggesting that spectral count is the most useful index for 
absolute or stoichiometric quantification based on the fre-
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3.2.2.2. Normalization with Observable Peptides 
  The number of observable peptides in each protein has 
been used as an alternative normalization factor. For in-
stance, the protein abundance index (PAI) is calculated by 
dividing the number of identified precursor ions by the num-
ber of theoretically observable tryptic peptides for each pro-
tein, to roughly estimate protein abundance [92]. This index 
was later refined to be emPAI or exponentially modified PAI 
(i.e., 10
PAI–1), where theoretically observable peptides were 
defined as those within a range of mass-to-charge ratio of 
scanning in mass spectrometer [93]. The emPAI demon-
strated its ability by successfully estimating absolute abun-
dance of 46 proteins, which had been measured using syn-
thetic peptides, with 2–3 of average deviation factor: more 
than 2- to 3-fold difference in absolute abundance can be 
detected with this index. The values of emPAI can be calcu-
lated so easily that it is quite useful in obtaining an approxi-
mation of absolute protein abundance in a large-scale analy-
sis. 
  Sequence coverage rate and the identification frequency 
per protein length or theoretically observable tryptic peptide 
kinds have a correlation with protein abundance and hence 
serve as useful indices to obtain absolute quantification data. 
Meanwhile, individual peptides have different propensities 
to be detected and identified by MS/MS analysis, not only 
because they differ in efficiency of proteolytic digestion, 
ionization, and detection in mass spectrometer, but because 
qualities and patterns of fragment ions are variable depend-
ing on their amino acid composition. 
  To sophisticate the approaches based on peptide and 
spectral count, observability of each peptide, or a probability 
that the peptide is identified with MS analysis, was recently 
introduced as a novel index [94, 95]. Absolute protein ex-
pression profiling approach, termed APEX, was developed 
where peptide observability was predicted from 4,023 tryptic 
peptides of 40 abundant proteins identified in a shotgun 
analysis of the yeast proteome [95]. Using this dataset con-
taining 714 observed and 3,309 not-observed peptides, a 
probability for identification of each peptide from the yeast 
proteome was calculated based on the frequencies of each 
amino acid, peptide length, and molecular weight. Redun-
dant spectral count was normalized by the sum of observ-
ability for each peptide from a corresponding protein and by 
the probability of protein identification calculated by Prote-
inProphet [96]. Resultant values were divided by the sum of 
the values of all identified proteins to generate an APEX 
score that would provide an absolute value of protein abun-
dance. APEX successfully measured the abundance of 10 
proteins, known amounts of which had been spiked into 
yeast cell extract, with mean difference of approximately 2-
fold at 2-order magnitude: this approach had an ability to 
detect more than 2-fold difference in protein abundance. 
  Another group computationally predicted observable 
peptides, termed ‘proteotypic peptides’, using a much larger 
dataset composed of more than 600,000 peptides from yeast 
proteins identified on four different experimental methods 
[97]. A proteotypic peptide is defined as the peptide that was 
detected in more than half of the proteomics studies in which 
the protein was detected. Approximately 500 physiochemical 
properties of more than 16,000 proteotypic peptides from 
4,030 yeast proteins were used to develop a classifier that 
distinguishes between proteotypic and non-proteotypic pep-
tides. Proteotypic peptides were successfully predicted with 
65–80% coverage and less than 10% error. As originally 
suggested [98], a dataset of proteotypic peptides would be of 
particular use in selecting peptides to be used as standards in 
quantification with stable isotope-labeling. It would be also 
useful to generate a library of selected information-rich pep-
tides for the reduction of time for database search and the 
improvement of accuracy of identification [99]. 
  Prediction of peptide observability is an important factor 
for normalization of identified peptide number and spectral 
count to generate a more accurate index for estimating pro-
tein abundance. However, it should be noted that the prob-
ability of peptide identification would be dependent on the 
experimental designs, types of MS instruments, and analyti-
cal conditions, as suggested by the studies of prediction for 
different data sets [100]. Indeed, propensity of a peptide to 
be proteotypic was shown to depend on experimental meth-
ods [97]. Thus, application of classification values generated 
from a dataset to other datasets may substantially compro-
mise both accuracy of prediction and coverage. Customized 
score for peptide observability may help generate more accu-
rate estimation of absolute protein abundance.  
4. COVERAGE AND DYNAMIC RANGE OF MASS 
SPECTROMETRY BASED PROTEOMICS 
  Current potential of MS-based proteomics still falls short 
of covering entire proteome. Fractionation of protein or pep-
tide mixture prior to MS can improve the coverage of protein 
identification over proteome. For yeast proteome, protein 
separation with SDS–PAGE prior to application to LC–MS 
analysis or peptide fractionations via  two- or three-
dimensional LC led to identification of 1,500–2,000 proteins 
[6-8, 101, 102]. However, even the coverage of these analy-
ses corresponds to ~30% of the yeast proteome. By contrast, 
western-blotting approach over yeast proteome, in which 
each yeast ORF tagged with TAP-tag was immunodetected, 
provided absolute quantity as copies per cell for 4,251 pro-
teins or ~70% of the total proteome [103]. While MS is a 
general system for protein identification that does not require 
any specific strains such as the tagged strains, its current 
sensitivity in detection of a particular protein in highly com-
plex samples (e.g., total cell extract) is substantially lower 
than targeted detection systems such as western-blotting. 
More recently, a high coverage of fly proteome was achieved 
by combining multiple separation procedures including frac-
tionation of cellular compartments, protein separation using 
gel filtration and isoelectric focusing, and peptide separation 
with multidimensional LC [104]. This study succeeded in 
cataloguing more than 9,000 proteins to cover ~60% of the 
fly proteome. Furthermore, combination of different types of 
MS and experimental methods proved to increase the sensi-
tivity of protein identification significantly [105, 106]. All 
possible means to increase coverage have to be combined to 
achieve a truly proteome-wide quantitative analysis. 
  Accurate quantification of absolute abundance requires 
high specificity and wide dynamic range. Background noise 
peak and co-detected irrelevant ions often interfere with de-
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ity and dynamic range. To reduce background noise and en-
hance specificity and dynamic range, SRM or MRM data 
acquisition mode, in which intensity of selected or multiple 
fragment ions other than peptide ion itself are monitored, 
have been used for measurement of absolute quantity [47, 
49, 51, 55, 64, 69]. Combination of SRM mode and protein 
separation with SDS-PAGE was shown to allow quantifica-
tion of low abundance proteins (10
3 copies per cell) [50]. 
Quantification in MRM mode for peptide mixture pre-
fractionated with strong cation-exchange LC allowed us to 
measure absolute amounts of proteins spiked in plasma at the 
concentration of 1–10 ng/ml [107]. High-resolution MS is an 
alternative technical basis to increase specificity and dy-
namic range, because it can better separate an analyte from 
co-eluting peptides with similar mass-to-charge ratio. High-
resolution can also generate spectrum with low background 
noise leading to an increase in dynamic range. For instance, 
LTQ-Orbitrap mass spectrometer [108], recently released 
into proteomics field, has achieved a strong linearity in quan-
tification of spiked proteins within 4-orders of dynamic 
range [109]. 
5. CONCLUSIONS 
  The pros and cons of stable isotope-labeling strategies 
and label-free approaches were summarized in terms of ab-
solute quantification (Table (1)). Methods based on stable 
isotope standard would provide accurate quantitative data, 
because of calculation via the ratio of co-detected ion pair, 
one from the target and the other from the standard. In these 
methods, quality of quantified peak (e.g., signal-to-noise 
ratio) is a critical factor to affect accuracy and dynamic 
range. By contrast, strategies for absolute quantification 
based on indices of normalized identification frequency are 
easy to implement with no additional experimental step and 
can be applied to a high throughput and comprehensive 
analysis. However, these methods have an intrinsic limita-
tion in their accuracy, in particular, for low abundance pro-
teins from which only a small number of peptides is identi-
fied. Assuming that both strategies would compensate with 
each other, we can propose a combined strategy where a 
proteome-wide estimation of abundance are achieved with 
label-free methods and corrected using a limited number of 
stable isotope-labeled standard spiked into the sample. 
Among the strategies using stable isotope labeling, the pep-
tide concatenation, such as PCS, would be the most versatile 
one to achieve accurate quantification of absolute protein 
abundance in a large scale. These quantitative techniques 
along with the advance in detection coverage would eventu-
ally lead to absolute quantification over whole proteome, 
thereby significantly contributing to both basic and applied 
studies in various fields of biology and medicine. 
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